ArticleResearch square2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Open access · greenAbstract readPreprint
In one paragraph
Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
120 authors at 20 institutions in 17 countries.
Anna Morra
Maartje A C Schreurs
Irene L Andrulis
Hoda Anton-Culver
Annelie Augustinsson
Matthias W Beckmann
Sabine Behrens
Stig E Bojesen
Manjeet K Bolla
Hiltrud Brauch
Annegien Broeks
Saundra S Buys
Nicola J Camp
Jose E Castelao
Melissa H Cessna
Jenny Chang-Claude
Wendy K Chung
Nbcs Collaborators
Sarah V Colonna
Fergus J Couch
Angela Cox
Simon S Cross
Kamila Czene
Mary B Daly
Joe Dennis
Peter Devilee
Thilo Dörk
Alison M Dunning
Miriam Dwek
Douglas F Easton
Diana M Eccles
Mikael Eriksson
D Gareth Evans
Peter A Fasching
Tanja N Fehm
Jonine D Figueroa
Henrik Flyger
Marike Gabrielson
Manuela Gago-Dominguez
Montserrat García-Closas
José A García-Sáenz
Jeanine Genkinger
Felix Grassmann
Melanie Gündert
Eric Hahnen
Christopher A Haiman
Ute Hamann
Patricia A Harrington
Jaana M Hartikainen
Reiner Hoppe
John L Hopper
Richard S Houlston
Anthony Howell
Abctb Investigators
kConFab Investigators
Anna Jakubowska
Wolfgang Janni
Helena Jernström
Esther M John
Nichola Johnson
Michael E Jones
Vessela N Kristensen
Allison W Kurian
Diether Lambrechts
Loic Le Marchand
Annika Lindblom
Jan Lubiński
Michael P Lux
Arto Mannermaa
Dimitrios Mavroudis
Anna Marie Mulligan
Taru A Muranen
Heli Nevanlinna
Ines Nevelsteen
Patrick Neven
William G Newman
Nadia Obi
Kenneth Offit
Andrew F Olshan
Tjoung-Won Park-Simon
Alpa V Patel
Paolo Peterlongo
Kelly-Anne Phillips
Dijana Plaseska-Karanfilska
Eric C Polley
Nadege Presneau
Katri Pylkäs
Brigitte Rack
Paolo Radice
Muhammad U Rashid
Valerie Rhenius
Mark Robson
Atocha Romero
Emmanouil Saloustros
Elinor J Sawyer
Rita K Schmutzler
Sabine Schuetze
Christopher Scott
Mitul Shah
Snezhana Smichkoska
Melissa C Southey
William J Tapper
Lauren R Teras
Rob A E M Tollenaar
Katarzyna Tomczyk
Ian Tomlinson
Melissa A Troester
Celine M Vachon
Elke M van Veen
Qin Wang
Camilla Wendt
Hans Wildiers
Robert Winqvist
Argyrios Ziogas
Per Hall
Paul D P Pharoah
Muriel A Adank
Antoinette Hollestelle
Marjanka K Schmidt
Maartje J Hooning
University of California, Irvine · USUniversity of Cambridge · GBKarolinska Institutet · SEGerman Cancer Research Center · DECancer Institute (WIA) · INInstitute of Cancer Research · CAWinnMed · USManchester Academic Health Science Centre · GBUniversitätsklinikum Erlangen · DEUniversity Hospital Ulm · DEUniversity of Utah · USAmerican Cancer Society · USColumbia University · USCopenhagen University Hospital · DKDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DELeiden University Medical Center · NLLund University · SEMedizinische Hochschule Hannover · DEMemorial Sloan Kettering Cancer Center · USPeter MacCallum Cancer Centre · AU
Funding
VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9MTransgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3MStatistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8MTissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KATHERINE A. HOADLEY · 1992 to 2026
$59.3MUniv.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9MThe Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9MUnderstanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4MUNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3MCALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7MGENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2MMultiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2MLong Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3MIntramural NIH HHS Z01 CP010119Intramural NIH HHS Z01 ES049030NCCDPHP CDC HHS NU58DP006344NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS K07 CA092044NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA023100NCI NIH HHS P30 CA033572NCI NIH HHS P30 CA062203NCI NIH HHS P50 CA058223NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA047147NCI NIH HHS R01 CA047305NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA058860NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA069664NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA097396NCI NIH HHS R01 CA116167NCI NIH HHS R01 CA128931NCI NIH HHS R01 CA128978NCI NIH HHS R01 CA132839NCI NIH HHS R01 CA140286NCI NIH HHS R01 CA163353NCI NIH HHS R01 CA176785NCI NIH HHS R01 CA177150NCI NIH HHS R01 CA192393NCI NIH HHS R35 CA253187NCI NIH HHS R37 CA054281NCI NIH HHS U01 CA058860NCI NIH HHS U01 CA063464NCI NIH HHS U01 CA098758NCI NIH HHS U01 CA164920NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA179715NCI NIH HHS U01 CA199277NCI NIH HHS U19 CA148065NCI NIH HHS U19 CA148112NCI NIH HHS U19 CA148537NCI NIH HHS U54 CA156733NCI NIH HHS UM1 CA164917NCI NIH HHS UM1 CA164920NCI NIH HHS UM1 CA164973NCI NIH HHS UM1 CA176726NCI NIH HHS UM1 CA186107NIEHS NIH HHS P30 ES010126Wellcome Trust
Abstract
Breast cancer (BC) patients with a germline
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.